Novel Anticoagulant Tops Slate of Hot Lines | MPT

ESC 2013 — AMSTERDAM — Leading off the Hot Line presentations at the European Society of Cardiology meeting, which kicks-off here Satuday, will be the Hokusai VTE trial evaluating a new oral anticoagulant — edoxaban — for venous thromboembolism.

Keywords: ESC Congress


< Back to Listings